Korn Jerald 4
4 · Epizyme, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Korn Jerald
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+800,000→ 800,000 totalExercise: $1.14Exp: 2032-03-31→ Common Stock (800,000 underlying)
Footnotes (2)
- [F1]This equity award was not granted pursuant to any pre-existing equity incentive plan of Epizyme, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
- [F2]This option was granted on April 1, 2022 with respect to 800,000 shares of Common Stock of the Company, with 25% vesting on April 1, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.